Results 51 to 60 of about 9,167 (208)
According to the European and American guidelines, surgery represents the treatment of choice for mitral valve (MV) disease. However, a number of patients are deemed unsuitable for surgery due to a prohibitive/high operative risk.
Giulio Russo +12 more
doaj +1 more source
Transcatheter Mitral Valve Replacement and Repair Technology [PDF]
The mitral valve is a two-cusp valve that is located between the left atrium and left ventricle of the heart. As blood flows from the lungs and enters the atrium, it must pass through this valve in one direction to enter the ventricle and be pumped out ...
Thomas, Joel
core +1 more source
Transcatheter mitral valve repair/replacement for primary mitral regurgitation [PDF]
This review outlines the first trial experience with transcatheter therapy for mitral regurgitation (MR), developed from the EVEREST II MitraClip trial in a trial population comprised predominantly of patients with degenerative mitral regurgitation (DMR).
Ted, Feldman +2 more
openaire +2 more sources
Transcatheter mitral valve interventions: pathophysiological considerations in choosing reconstruction versus transcatheter valve implantation [PDF]
Over the last few years, several surgical procedures to treat mitral regurgitation (MR) in high-risk or inoperable patients have inspired percutaneous devices, including valve repair and valve replacement technologies.
Maisano, Francesco, Taramasso, Maurizio
core +1 more source
Technologies in minimally invasive treatment of severe mitral regurgitation
Mitral valve regurgitation is the second most common valve defect in Europe among adults. Primary mitral regurgitation (MR) results from structural abnormalities of the valve apparatus (e.g., leaflet prolapse, chordae rupture), often due to myxomatous ...
Magdalena Synak +8 more
doaj +1 more source
Economic Burden of Inpatient Care for Mitral Regurgitation in Maryland
Background Mitral regurgitation (MR) is the most common valvular disease in the United States and increases the risk of death and hospitalization. The economic burden of MR in the United States is not known.
Radoslav Zinoviev +4 more
doaj +1 more source
Mitral regurgitation is the most common valve disorder in the Western world, and although surgery is the established therapeutic gold standard, percutaneous transcatheter mitral interventions are gaining acceptance in selected patients who are inoperable
Lorenzo Faggioni +7 more
doaj +1 more source
Successful Transcatheter Closure of Iatrogenic Mitral Regurgitation After Aortic Valve Surgery
We present 2 cases of significant mitral regurgitation secondary to pericardial patch avulsion from the anterior mitral valve leaflet after aortic valve replacement with aortic annulus enlargement.
Thomas J. Stocker, MD +4 more
doaj +1 more source
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer +9 more
wiley +1 more source
Background: Mitral valve repair is a widely used operation to treat mitral regurgitation. However, the annuloplasty ring used may fail, causing mitral regurgitation to recur several years after the operation. Transcatheter mitral valve-
Tingqian Cao +7 more
doaj +1 more source

